Gelteq Ltd
Business
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and sports nutrition products. The company's principal products are edible gels with patent-pending multiple-ingredient dosage forms organized across five core verticals: pet, pharmaceutical, over-the-counter, nutraceutical and sports nutrition. Gelteq out-licenses its gel technology to third-party companies for product development and manufacturing while maintaining proprietary intellectual property including granted patents in multiple jurisdictions.
Summary from 20-F filed 2025-11-17
Financials
Latest annual snapshot (FY2025, period end 2025-06-30). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-6.65M |
| Total assets | $21.48M |
| Total liabilities | $5.67M |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Gelteq Ltd's CIK number?
Gelteq Ltd's SEC CIK number is 0001920092 (1920092). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Gelteq Ltd's SEC filings?
All of Gelteq Ltd's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.